Abbreviations: AP-1 is activator protein-1; AhR is aryl hydrocarbon receptor; Arnt is aryl hydrocarbon receptor nuclear translocator; CAR is constitutive androstane receptor; Epo is erythropoietin; Erk is extracellular signal-regulated kinase; FiO 2 is fractional concentration of inspired O 2 ; H CONT is hepatocytes from control rabbits; H HYPO is hepatocytes from rabbits with hypoxia; HIF-1 is hypoxia-inducible factor 1 transcriptional activator; IFN-γ is interferon-γ; IL-1β is interleukin-1β; MDR1 is multidrug resistance protein 1; M r is relative molecular mass; OATP2 is organic anion transporting polypeptide 2; P450 is cytochrome P450; PXR is pregnane X receptor; ROS is reactive oxygen intermediates; S CONT is serum from control rabbits; S HYPO is serum from rabbits with hypoxia; TNF-α is tumour necrosis factor; WME is William's medium E.
DMD #13508

Introduction
In patients with cardio-respiratory diseases, acute hypoxemia appears to reduce the ability of cytochrome P450 isoforms to catalyze the biotransformation of xenobiotics. Patients with pulmonary insufficiency showing an impairment of their general state present an increased incidence of adverse effects, e.g. grand mal seizures, associated with the administration of "usual" doses of theophylline. Theophylline clearance is significantly reduced in patients with acute cardiogenic pulmonary edema (Piafsky et al., 1977) , and in patients with worsening airway obstruction, severe bronchial obstruction, congestive heart failure, and pneumonia (Vozeh et al., 1978) .
In humans, at therapeutic concentrations, the biotransformation of theophylline is primarily catalyzed by CYP1A2, while CYP2D6, 2E1 and 3A4 exhibit low affinity and variable capacity (Ha et al., 1995) . Rabbits exposed to a fractional concentration of inspired O 2 (FiO 2 ) of 10% for 24 h demonstrate a reduced clearance of theophylline and decreased expression of CYP1A1 and 1A2, although the expression of CYP3A6 is increased (Kurdi et al., 1999) . In rabbits subjected to acute moderate hypoxia, hepatic down-regulation of CYP1A1 and 1A2 is triggered by serum mediators, e.g. interferon-γ (IFN-γ), interleukine-2 (IL-2) and IL-1β; the up-regulation of CYP3A6 is, at least in part, associated with erythropoietin (Epo) (Fradette et al., 2002) . In vivo, the increase in CYP3A6 by hypoxia is associated with the increased expression and nuclear translocation of hypoxia inducible factor-1 (HIF-1), activator protein-1 (AP-1) and constitutive androstane receptor (CAR) (Fradette and du Souich, 2003) .
There is indirect evidence that in addition to CYP1A1 and 1A2, hypoxemia down-regulates other cytochrome P450 isoforms. Effectively, antipyrine half-life was increased 120% in a group of patients predominantly with chronic hypoxemia (PaO 2 < 55mm Hg) from a variety of causes, DMD #13508 when compared with other subjects without severe hypoxia (Cumming, 1976) . In humans, antipyrine is metabolized by numerous hepatic CYP isozymes, e.g. CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C18, 2C19 and 3A4 (Engel et al., 1996; Sharer and Wrighton, 1996) .
The present study aimed to explore whether acute moderate hypoxia down-regulates CYP2B4, 2C5 and 2C16 in vivo, the rabbit's orthologs of human CYP2B6, 2C9 and 2C19, respectively, because of their relative importance in the biotransformation of drugs, and to identify ex vivo the serum mediators implicated in the in vivo down-regulation of these hepatic isoforms. On the other hand, P-glycoprotein is modulated by CAR (Burk et al., 2005) , and by the presence of reactive oxygen species (Wartenberg et al., 2003) which are increased by acute moderate hypoxia (Fradette and Du Souich, 2004) ; moreover, the multidrug resistance protein 1 (MDR1) gene contains a binding site for HIF-1 (Wartenberg et al., 2003) . Thus, we hypothesized that in vivo hypoxia would increase the expression of the P-glycoprotein MDR1 (multidrug resistance gene product, ABCB1). Therefore, the present study also aimed to document in vivo the effect of moderate hypoxia on several efflux and influx membrane transporters. DMD #13508 sterile conditions. Viability was assessed by trypan blue exclusion to ensure that it was greater than 90%; viability was not affected by in vivo hypoxia or any other experimental condition. Cell concentration was adjusted to 1 x 10 6 cells per ml with William's medium E (WME)
supplemented with 10% calf serum and 1 µM insulin. Aliquots of 2 ml of the hepatocytes in suspension were transferred into 6-well plastic culture plates (Falcon, Becton Dickinson Labware, Rutherford, NJ) coated with type 1 rat tail collagen and incubated for 2 h at 37°C in an atmosphere of 95% air and 5% CO 2 to allow for stabilization before any experiment was undertaken.
Characterization of serum mediators
Blood samples (10 ml) were withdrawn from the rabbits 48 h after the induction of hypoxia and from control rabbits in a sterile Vacutainer Brand SST (Becton Dickinson, Mississauga, ON, Canada). Blood samples were allowed to clot at room temperature for 2 h, thereafter were centrifuged at 2500 r.p.m. for 5 min, and the serum was decanted and stored frozen at -20°C in 1 ml aliquots until use. Preliminary studies have shown that when samples were handled as described, serum mediators conserved their activity for up to 12 months.
Proteins in the serum were separated by size exclusion high performance liquid chromatography (HPLC) on a Superose 12 HR column from Pharmacia Biotech (Baie d'Urfé, Québec, Canada) as previously described (Fradette et al., 2002) . Briefly, flow rate of the mobile phase was set at 0.3 ml min -1 and column pressure was maintained between 9 to 12 bar with a DMD #13508 8 of 300 µl were injected into the column and fractions of 1.2 ml were collected with a fraction collector (LKB 2211 Superrac). To calculate the relative molecular mass (M r ) of the serum proteins contained in each HPLC fraction, a calibration curve was established by injecting 300 µl of the buffer containing a mixture of six standard proteins (100 µg ml -1 ): L-glutamic dehydrogenase (55.6 kDa), aldolase (39.2 kDa), triosephosphate isomerase (26.6 kDa), trypsin inhibitor (26.6 kDa), cytochrome c (12.5 kDa) and aprotinin (6.5 kDa). The fractions containing proteins with M r between 9 and 14 kDa, 15 and 23 kDa, 24 and 31 kDa, 32 and 44 kDa, 45 and 64 kDa, and 65 and 94 kDa were separated and collected. Based on the size exclusion range of the column, proteins isolated in the first fraction were assumed to have a M r greater than 95 kDa.
In order to increase the inhibitory activity of the fractions collected, these were concentrated on Microsep 3K membranes (Pall Filtron, Northborough, MA. U.S.A.) that retain proteins greater than 3 kDa. Three ml of the fractions were added to the sample reservoir and centrifuged at 75000 x g to reduce the volume and hence concentrate serum fractions 1.25 times.
The medium of the cultured hepatocytes was replaced with fresh WME supplemented with The identification of the serum mediators was performed by immuno-neutralization. The selection of the antibodies used for the immuno-neutralization of cytokines was based a) upon the M r of the proteins incorporated in the HPLC fractions having the ability to change P450 isoforms expression, and b) according to the cytokines released during hypoxia (Naldini et al., 1997 The antibodies against human proteins were used to neutralize the homologous rabbit proteins because of the known inter-species reactivity of these antibodies (Fradette et al., 2002 ). An IgG monoclonal antibody to Pseudomona aeruginosa served as control. Aliquots of 2 µg of each antibody were added individually to 200 µl of the HPLC fractions that were able to decrease the expression of P450 isoforms, and were incubated at 37°C for 1 h. The antibody and the HPLC fractions were incubated with the hepatocytes for 24 h when P450 isoform expression was assessed. The amount of 2 µg of antibodies was used since this amount is effective to immunoneutralize IL-1β, IL-6, and IFN-γ in the sera of rabbits and of humans with an inflammatory reaction (Fradette et al., 2002) .
Measure of P450 isoforms by immunoblot
Hepatocytes were washed, harvested in ice-cold PBS and centrifuged at 1500g for 5 min.
The pellet was resuspended in cold lysis buffer (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, protease inhibitor mixture), and cells were allowed to swell on ice for 15 min, and vortexed for 30 s. The amount of protein in hepatocytes was measured in cell lysate by the method of Lowry (Lowry et al., 1951) . For Western blot analysis, 50 µg of cell lysate were separated by SDS-polyacrylamide gel electrophoresis (Fradette et al., 2002) . Separated proteins were electrophoretically transferred to a nitro-cellulose membrane using a semi-dry transfer process (Bio-Rad, Hercules, CA, U.S.A. As reference protein, in each gel, 50 µg of proteins extracted from the same control hepatocytes, with constant amounts of CYP1A1, 1A2, 2B4, 2C5, 2C16 and 3A6. The assays were linear in the range of protein amounts assessed under the actual experimental conditions, and the results are presented as a ratio of the P450 isoform to the reference protein.
Effect of hypoxia on the expression of membrane transporters
These experiments were conducted with rats due to the lack of information and commercial availability of antibodies for transporters in rabbit. Preliminary experiments showed that a FiO 2 of 8% reduced the arterial partial pressure to similar levels as those measured in rabbits, e.g.
around 35 mm Hg, and that after 48 h the expression of CYP3A1 was induced consistent with that seen in rabbits.
Male Sprague-Dawley rats (250-275 g) were purchased from Charles River Canada (St.
Constant, QC, Canada), and studies were conducted in accordance with the guidelines of the Canadian Council on Animal Care. Rats were exposed for 48 h to a FiO 2 of 8% in the chamber as described above. Control rats were placed into chambers which contained room air (FiO 2 = 21%)
for the experiments. Forty eight hours later, the rats were anaesthetized with halothane and the liver removed, rapidly frozen in liquid N 2 and stored at -80°C until used for protein and RNA This article has not been copyedited and formatted. The final version may differ from this version. isolation. The expression of CYP3A1 was measured from the microsomal fraction of the liver as described above. To further validate the rat model, preliminary experiments showed that the effect of 48 h of hypoxia in vivo on the expression of P450 isoforms was not affected by the approach used, e.g. measure of P450 isoforms in microsomes or in cultured hepatocytes.
Analysis of Mdr, OATP, BCRP and PXR expression.
Total RNA was isolated from rat liver using the QuickPrep RNA extraction kit The hepatic crude membrane fraction was isolated as described previously (Teng and Piquette-Miller, 2005) and measured by the Bradford method using the Bio-Rad protein assay (Bio-Rad, Hercules, CA) (Bradford, 1976 
Drugs and Chemicals
Percoll gradient, William's medium E, calf serum, type I rat tail collagen, NaCl, KCl, 
Statistical analysis
All results are presented as mean ± s.e. The comparison of the results from the various experimental groups and their corresponding controls was carried out by a one-way analysis of variance (ANOVA), followed by the Newman-Keuls post hoc test. Differences were considered significant when p<0.05.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Effect of hypoxia in vivo on hepatic P450 isoform expression
Exposure of rabbits to an 8 % FiO 2 atmosphere for 48 h generated a stable hypoxemia, with an average arterial partial pressure of O 2 (PaO 2 ) of 34 ± 1 mmHg, without influencing the arterial partial pressure of CO 2 (≈ 21 ± 1) and arterial pH (7.47 ± 0.05). Compared with rabbits breathing a 21% FiO 2 (i.e. room air), hypoxia reduced the amount of CYP1A1, 1A2, 2B4, 2C5 and 2C16
proteins by 37%, 40%, 55%, 75% and 82%, respectively (p<0.05, n = 6 per group). On the other hand, 48 h of hypoxia increased the amount of CYP3A6 by 71% (Figure 1 ).
Effect of serum from control rabbits (S CONT ) and serum of rabbits with hypoxia (S HYPO ) on hepatic P450 isoform expression in H CONT and in H HYPO
As compared to H CONT incubated with S CONT , incubation of H CONT with S HYPO for 24 h reduced the amount of CYP2C5 and 2C16 by 15% and 17%, respectively (p<0.05). Moreover, S HYPO increased the amount of CYP3A6 by 31% (p<0.05, n = 6). No changes in CYP1A1, 1A2
and 2B4 proteins were observed (Figure 2A ).
In H HYPO incubated with S CONT , the expression of CYP1A1, 1A2, 2B4, 2C5 and 2C16 were reduced by 33, 35, 42, 70, and 77%, respectively (p<0.05, n = 6) , and that of CYP3A6 was increased by around 70% (p<0.05), compared with H CONT ( Figure 2B ). Following 24 h incubation of H HYPO with S HYPO , the amount of CYP1A1 and 1A2 proteins were further reduced by an average of 27 and 30%, respectively (p<0.05) whereas the amount of CYP2B4, 2C5 and 2C16 decreased to an undetectable level. On the other hand, incubation of H HYPO with S HYPO increased the expression of CYP3A6 by an average of 50% (p<0.05) ( Figure 2B ).
Effect of S HYPO HPLC fractions on P450 isoform expression in H HYPO
This article has not been copyedited and formatted. The final version may differ from this version. Identification of the mediators in S HYPO responsible for the changes in the expression of
P450 isoforms
As compared with the incubation with the S HYPO 15-23 kDa fraction, which significantly reduced the expression of all CYP isoforms in H HYPO cells, co-incubation of these sera with several antibodies influenced this change. Addition of an anti-IL-2 antibody partially prevented the decrease of CYP1A1 and 2C19 (n = 6); anti-IL-1β antibody partially attenuated the downregulation of CYP1A1, 2B4, 2C5 and 2C16 (n = 6); finally, anti-IFN-γ antibody (n = 6) prevented the down-regulation of CYP1A1, 1A2, 2B4, 2C5, 2C16 and 3A6. The anti-IL-6 antibody (n = 6) did not elicit any effect on P450 isoform expression, despite increasing the amount of antibody to 4 µg (data not shown).
While the S HYPO 32-44 kDa fraction significantly increased CYP3A6 expression by around 80%; co-incubation of an anti-Epo antibody (n = 6) to the 32-44 kDa fraction attenuated CYP3A6 protein induction by 40% (p<0.05). However, CYP3A6 expression was still greater (p<0.05) than that observed in the S CONT treated H HYPO cells (Figure 4) .
Effect of moderate hypoxia on the expression of membrane transporters
This article has not been copyedited and formatted. The final version may differ from this version. (p<0.05, n = 9) in hypoxic rats exposed to a FiO 2 of 8% for 48 h ( Figure 5 ). Levels of CYP3A1 mRNA were also similarly induced in hypoxic rats (data not shown). Levels of mdr1b mRNA was significantly induced in hypoxic rats(p<0.05, n = 9), however hypoxia did not affect the expression of Mdr1a, OATP2 and BCRP mRNAs. Likewise, protein levels of P-glycoprotein were significantly increased by 77% in hypoxic rats (p<0.05, n = 9) (Figure 7 ). Hypoxia tended to increase PXR mRNA (p>0.05, n = 9) ( Figure 6 ).
Discussion
The present study demonstrates that besides CYP1A1 and 1A2, acute moderate hypoxia down-regulates CYP2B4, 2C5, and 2C16 in vivo, the orthologs of human CYP2B6, 2C9 and 2C19, respectively. The serum mediators contributing to the decrease in expression of these isoforms are IFN-γ, IL-1β and IL-2. This study confirms that acute moderate hypoxia as well as serum from rabbits with hypoxemia up-regulate the expression of CYP3A6, in part due to Epo (Fradette et al., 2002) . Hypoxia in vivo and S HYPO induce the expression of CYP3A6 through a protein tyrosine kinase-and an extracellular signal-regulated kinase 1/2 (Erk1/2)-dependent activation of HIF-1 and AP-1 nuclear translocation (Fradette and du Souich, 2003) . The decrease in CYP1A1 and 1A2 expression by hypoxia occurs at the transcriptional level (Fradette et al., 2002 ).
The serum mediators responsible for the down-regulation of CYP1A1, 1A2, 2B4, 2C5 and 2C16 are primarily IFN-γ and IL-1β, with IL-2 playing a minor role (Table 1) . It is noteworthy that the cytokines modulating P450 isoforms depend upon the experimental condition. For instance, in hypoxia, IL-6 does not contribute to the decrease in expression of P450 isoforms, contrasting with the turpentine-induced inflammatory reaction, where IL-6 is the most important serum mediator involved in the down-regulation of CYP1A1, 1A2 and 3A6 (Bleau et al., 2003) .
Moreover, IFN-γ is the predominant mediator in acute moderate hypoxia and in the serum from humans with an upper respiratory viral infection, whereas IFN-γ does not modulate the expression of P450 isoforms in the turpentine-induced inflammatory reaction (Bleau et al., 2003) .
IFN-γ does not appear to be selective since it contributes to the down-regulation of all P450
isoforms investigated. On the other hand, in the serum of rabbits with hypoxia, IL-1β contributes to the down-regulation of CYP1A1, 2B4 and 2C5, whereas in the serum of rabbits with a This article has not been copyedited and formatted. The final version may differ from this version. Moreover, the effect of serum from hypoxic rabbits depends upon the source of hepatocytes, e.g.
the down-regulation of CYP1A1, 1A2, 2B4, 2C5 and 2C16 and the up-regulation of CYP3A6
after 24 h of incubation with serum from rabbits with hypoxia is marginal in hepatocytes from control rabbits but extensive in hepatocytes from rabbits with hypoxia. Similar differences occur when serum from rabbits with an aseptic inflammatory reaction is incubated with hepatocytes from control rabbits or with hepatocytes from rabbits with an inflammatory reaction. The differences in response to serum fade when incubations are conducted for longer periods, e.g. 48
h (El-Kadi et al., 1997; Bleau et al., 2003) . The differences in response to serum may be associated to the expression of cytokine membrane receptors which is enhanced by increased serum concentrations of cytokines secondary to the inflammatory reaction and hypoxia (Geisterfer et al., 1993; Naldini et al., 1997) .
Considering CYP1A1 and 1A2, at least three mechanisms may contribute to their decrease in expression by hypoxia. In vivo, hypoxia induces the production of reactive oxygen species (ROS) in the liver (Fradette and Du Souich, 2004) , which may activate nuclear factor-κB (NF-κB) which can, in turn, interact with the aryl hydrocarbon receptor (AhR). This leads to a mutual functional repression of AhR by NF-κB, and consequently, to a reduction of the expression of CYP1A1 and CYP1A2 (Tian et al., 1999) .
Hypoxia also activates transcription factors which regulate adaptive responses in cells (Semenza, 2000) . Cells adapt to low partial pressure of oxygen by up-regulating the transcription of multiple genes, such as vascular endothelial growth factor, Epo, and several glycolytic enzymes. These target genes are induced by a common transcription factor, HIF-1 (Aragones et translocates to the nucleus where it dimerizes with HIF-1β or aryl hydrocarbon receptor nuclear translocator (Arnt) to form HIF-1. Since Arnt is also a heterodimerization partner of AhR, hypoxia will decrease the availability of Arnt and so cause a down-regulation of CYP1A1 and 1A2 (Chan et al., 1999) . Supporting that hypoxia reduces CYP1A1 and 1A2 by decreasing the availability of Arnt is the fact that stabilization of HIF-1α with cobalt chloride decreases CYP1A1 and 1A2 expression (Fradette and du Souich, 2003) .
Activator protein-1 (AP-1) is activated by hypoxia by the increase in intracellular calcium.
Hypoxia, increases intracellular calcium that activates Erk1/2 with the subsequent induction of the immediate-early-response genes c-fos, c-jun and erg-1 (Michiels et al., 2000) . Dimerization of these early response genes forms AP-1, which binds to DNA to modulate gene transcription. , 1997) . There is evidence that CYP1A1 down-regulation by IL-1β and IFN-γ depends upon the activation of AP-1 (Abdel-Razzak et al., 1994) . On the other hand, we have shown that activation of AP-1 by lead acetate increases its nuclear translocation as well as the downregulation of CYP1A1 and CYP1A2 in hepatocytes (Fradette and du Souich, 2003) . All these data suggest that AP-1 could contribute to the CYP1A1 and 1A2 down-regulation.
CYP1A1 and 1A2 negative regulatory element (NRE) contains AP-1 motifs (Chung and
Hypoxia promotes the release of cytokines including IL-1β, IL-2, IL-4, IL-5, IL-6, TNF-α and IFN-γ (Naldini et al., 1997) . The increase in IL-1β, IL-2, and IFN-γ activate transcription factors, such as NF-κB, AP-1 and c-myc (Wesselborg et al., 1997; Ellery and Nicholls, 2002) .
There is evidence that in response to IL-1β, the p50 subunit of NF-κB binds to the negative κB response element 1 of the CYP2C11 gene, entailing a down-regulation of CYP2C11 (Iber et al., 2000) . Moreover, c-myc diminishes the expression of P450 isoforms by decreasing CCAATThis article has not been copyedited and formatted. The final version may differ from this version. enhancer binding protein-α-mediated P450 transactivation (Tinel et al., 2003) . Therefore, probably multiple mechanisms contribute to the modulation of CYP1A1, 1A2, 2B4, 2C5 and 2C16 expression during hypoxia.
The present results afford a mechanism to early reports showing that in humans and animals, hypoxia modulates the clearance of drugs. For instance, antipyrine half-life is increased in hypoxic subjects (Cumming, 1976) possibly because antipyrine is biotransformed by CYP1A2, 2B6, 2C8, 2C9, 2C18, and 3A4 (Engel et al., 1996) . Acute moderate hypoxia reduces the clearance of phenytoin, which is biotransformed primarily by CYP2C9 and to a minor degree by CYP2C19 (Giancarlo et al., 2001 ). On the other hand, the clearance of lidocaine and diltiazem is not affected by hypoxia, two drugs primarily metabolized by CYP3A6 in rabbits (Fradette and Du Souich, 2004) .
The present results demonstrate that in vivo, acute moderate hypoxia increases the expression of the efflux transporter P-glycoprotein in hepatocytes as well as Mdr1b mRNA. These results confirm in vitro results showing that hypoxia reduces the sensitivity of EMT6/Ro cells to doxorubicin, adriamycin, 5-fluorouracil, and actinomycin D because of an amplification of Pglycoprotein gene family (Sakata et al., 1991) . Induction of P-glycoprotein as well as the breast cancer resistance protein (BCRP) and the organic anion transporting polypeptide 2 (OATP2)
frequently occur through activation of the pregnane X receptor (PXR) (Anapolsky et al., 2006) , however this mechanism did not appear to play an important role in hypoxic animals as mRNA levels of BCRP and OATP2 as well as PXR were not affected. Alternatively it is plausible that binding sites for HIF-1, found on the promoter region of MDR1 (Krishnamurthy et al., 2004) , may be involved in the observed hypoxia-mediated induction of P-glycoprotein. Hypoxiainduced resistance to chemotherapy, which is associated with the overexpression of Mdr1 and This article has not been copyedited and formatted. The final version may differ from this version. MRP1 genes, is believed to be mediated through HIF-1 activation, depending in part through signaling via the stress-activated protein kinase c-Jun NH 2 -terminal kinase (Comerford et al., 2004) . Recent reports also indicate that HIF-1α silencing increases chemosensitivity of nonsmall cell lung cancer and breast carcinoma to cisplatin, doxorubicin and methotrexate (Song et al., 2006) . Overall, these studies suggest that multiple signaling pathways may be implicated in hypoxia-induced drug resistance (Dixit et al., 2005) .
Besides systemic hypoxia, there are other experimental pathological conditions that can modulate the expression of membrane transporters. For instance, acute renal and acute hepatic failure (Murakami et al., 2002) , as well as local and systemic inflammatory reactions (Ho and Piquette-Miller, 2006) reduce the expression of P-glycoprotein. The fact that in vivo acute moderate systemic hypoxia increases the expression of P-glycoprotein may have clinical implications concerning drug response in patients presenting acute hypoxia of respiratory or cardiac origin with or without nocturnal desaturation.
In conclusion, acute moderate hypoxia diminishes the expression of CYP1A1, 1A2, 2B4, 2C5, and 2C16, effect mediated by IFN-γ, IL-1β and IL-2, but increases that of CYP3A6, effect partially mediated by Epo. In addition, acute moderate hypoxia increases the expression of Pglycoprotein. The net result of these changes on the kinetics of drugs will depend upon the isoform involved in their biotransformation. We may predict that the area under the concentration-time curve (AUC) of substrates of CYP3A will be smaller do to decreased absorption, and increased first pass and systemic/renal clearance. For substrates of the subfamilies CYP1A, 2B and 2C, hypoxia shall reduce their clearance and the repercussions on the AUC will depend on whether these drugs are or not substrates of P-glycoprotein. On the other This article has not been copyedited and formatted. The final version may differ from this version. fractions to modify the expression CYP1A1, 1A2, 2B4, 2C5, 2C16 and 3A6 apoproteins incubated for 24 h with hepatocytes from rabbits with acute moderate hypoxia (n = 6). S CONT is serum from control rabbits; Epo is erythropoietine; IL-2, IL-1β, IL-6 and IFN-γ are interleukin-2, -1β, -6 and interferon-γ, respectively. Data is mean ± standard error of densitometric ratios (* p<0.05 compared with control). Figure 5 . Effect of hypoxia on CYP3A1 expression in rat liver. Rats were exposed to room air (control) or to a FiO 2 of 8% (hypoxic) for 48 h. The liver was harvested and CYP3A1 was measured by immunoblot and normalized to its reference protein control as described in methods.
Data is represented as mean ± standard error of densitometric ratios in control (n=6) and hypoxic (n=9) rats (* p<0.05). Representative blots demonstrate CYP3A1 levels in three hypoxic and three control rats. Figure 6 . Effect of hypoxia on transporter and PXR mRNA expression in rat liver. Rats were exposed to room air (control) or to a FiO 2 of 8% (hypoxic) for 48 h. The liver was harvested and total RNA was extracted. The mRNA levels of Mdr1a, Mdr1b, OATP2, BCRP and PXR were measured by real-time quantitative PCR and normalized to levels of 18S mRNA as described in methods. Bars graphs represent the mean± standard error in control (n=6) and hypoxic (n=9) rats ( *p<0.05 versus controls). Figure 7 . Effect of hypoxia on P-glycoprotein protein expression in rat liver. Rats were exposed to room air (control) (n = 6) or to a FiO 2 of 8% (n = 9) for 48 h. The liver was harvested, and the crude membrane protein fraction was isolated. P-gp levels were measured by western blotting as described in Materials and Methods, and normalized to β -actin levels. Vertical bars are SEM.
*p<0.05 versus controls.
This article has not been copyedited and formatted. The final version may differ from this version. Table 1 . Effect of cytokines on the expression of CYP1A1, 1A2, 2B4, 2C5, 2C16 and 3A6. Hepatocytes were incubated with serum from rabbits subjected to 48 h hypoxia in the presence of an anti-cytokine antibody for 24 h. The signs + and -indicate the effect of the immunoneutralization on the expression of the isoforms; ≈ indicates no effect on the isoform. 
